 | • レポートコード：QYR2104Z1695 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、サイクリン依存性キナーゼ阻害剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（広範囲用CDK阻害剤、特定用CDK阻害剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・サイクリン依存性キナーゼ阻害剤の市場動向 ・企業の競争状況、市場シェア ・サイクリン依存性キナーゼ阻害剤の種類別市場規模（広範囲用CDK阻害剤、特定用CDK阻害剤） ・サイクリン依存性キナーゼ阻害剤の用途別市場規模（病院、クリニック、その他） ・サイクリン依存性キナーゼ阻害剤の北米市場規模2016-2027（アメリカ、カナダ） ・サイクリン依存性キナーゼ阻害剤のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・サイクリン依存性キナーゼ阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・サイクリン依存性キナーゼ阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・サイクリン依存性キナーゼ阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly、Pfizer、Novartis、Astex Pharmaceuticals、Merck、Bio-Techne、Sanofi、Bayer、Syros Pharmaceuticals、Amgen、BioCAD、Otsuka Pharmaceutical） ・結論 |
Cyclin-dependent kinase inhibitor function as tumor suppressor proteins by inhibiting the enzyme cyclin-dependent kinase. The enzyme cyclin-dependent kinase controls cell cycle progression, transcription, mRNA processing, and differentiation. Cyclin-dependent kinase inhibitor arrest cell cycle at the G1 phase leading to mitosis. Cyclin-dependent kinase inhibitors are employed in the treatment of cancers by preventing over proliferation of cancer cells. Cyclin-dependent kinase are very active in most cancers which is rational to the use of cyclin-dependent kinase inhibitor as anti-cancer agents.
Market Analysis and Insights: Global Cyclin Dependent Kinase Inhibitor Market
The global Cyclin Dependent Kinase Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cyclin Dependent Kinase Inhibitor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cyclin Dependent Kinase Inhibitor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cyclin Dependent Kinase Inhibitor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cyclin Dependent Kinase Inhibitor market.
Global Cyclin Dependent Kinase Inhibitor Scope and Market Size
Cyclin Dependent Kinase Inhibitor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cyclin Dependent Kinase Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Broad CDK inhibitors
Specific CDK inhibitors
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eli Lilly
Pfizer
Novartis
Astex Pharmaceuticals
Merck
Bio-Techne
Sanofi
Bayer
Syros Pharmaceuticals
Astex Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cyclin Dependent Kinase Inhibitor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Broad CDK inhibitors
1.2.3 Specific CDK inhibitors
1.3 Market by Application
1.3.1 Global Cyclin Dependent Kinase Inhibitor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cyclin Dependent Kinase Inhibitor Market Perspective (2016-2027)
2.2 Cyclin Dependent Kinase Inhibitor Growth Trends by Regions
2.2.1 Cyclin Dependent Kinase Inhibitor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cyclin Dependent Kinase Inhibitor Historic Market Share by Regions (2016-2021)
2.2.3 Cyclin Dependent Kinase Inhibitor Forecasted Market Size by Regions (2022-2027)
2.3 Cyclin Dependent Kinase Inhibitor Industry Dynamic
2.3.1 Cyclin Dependent Kinase Inhibitor Market Trends
2.3.2 Cyclin Dependent Kinase Inhibitor Market Drivers
2.3.3 Cyclin Dependent Kinase Inhibitor Market Challenges
2.3.4 Cyclin Dependent Kinase Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cyclin Dependent Kinase Inhibitor Players by Revenue
3.1.1 Global Top Cyclin Dependent Kinase Inhibitor Players by Revenue (2016-2021)
3.1.2 Global Cyclin Dependent Kinase Inhibitor Revenue Market Share by Players (2016-2021)
3.2 Global Cyclin Dependent Kinase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cyclin Dependent Kinase Inhibitor Revenue
3.4 Global Cyclin Dependent Kinase Inhibitor Market Concentration Ratio
3.4.1 Global Cyclin Dependent Kinase Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cyclin Dependent Kinase Inhibitor Revenue in 2020
3.5 Cyclin Dependent Kinase Inhibitor Key Players Head office and Area Served
3.6 Key Players Cyclin Dependent Kinase Inhibitor Product Solution and Service
3.7 Date of Enter into Cyclin Dependent Kinase Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cyclin Dependent Kinase Inhibitor Breakdown Data by Type
4.1 Global Cyclin Dependent Kinase Inhibitor Historic Market Size by Type (2016-2021)
4.2 Global Cyclin Dependent Kinase Inhibitor Forecasted Market Size by Type (2022-2027)
5 Cyclin Dependent Kinase Inhibitor Breakdown Data by Application
5.1 Global Cyclin Dependent Kinase Inhibitor Historic Market Size by Application (2016-2021)
5.2 Global Cyclin Dependent Kinase Inhibitor Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cyclin Dependent Kinase Inhibitor Market Size (2016-2027)
6.2 North America Cyclin Dependent Kinase Inhibitor Market Size by Type
6.2.1 North America Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2021)
6.2.2 North America Cyclin Dependent Kinase Inhibitor Market Size by Type (2022-2027)
6.2.3 North America Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2027)
6.3 North America Cyclin Dependent Kinase Inhibitor Market Size by Application
6.3.1 North America Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2021)
6.3.2 North America Cyclin Dependent Kinase Inhibitor Market Size by Application (2022-2027)
6.3.3 North America Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2027)
6.4 North America Cyclin Dependent Kinase Inhibitor Market Size by Country
6.4.1 North America Cyclin Dependent Kinase Inhibitor Market Size by Country (2016-2021)
6.4.2 North America Cyclin Dependent Kinase Inhibitor Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cyclin Dependent Kinase Inhibitor Market Size (2016-2027)
7.2 Europe Cyclin Dependent Kinase Inhibitor Market Size by Type
7.2.1 Europe Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2021)
7.2.2 Europe Cyclin Dependent Kinase Inhibitor Market Size by Type (2022-2027)
7.2.3 Europe Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2027)
7.3 Europe Cyclin Dependent Kinase Inhibitor Market Size by Application
7.3.1 Europe Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2021)
7.3.2 Europe Cyclin Dependent Kinase Inhibitor Market Size by Application (2022-2027)
7.3.3 Europe Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2027)
7.4 Europe Cyclin Dependent Kinase Inhibitor Market Size by Country
7.4.1 Europe Cyclin Dependent Kinase Inhibitor Market Size by Country (2016-2021)
7.4.2 Europe Cyclin Dependent Kinase Inhibitor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size (2016-2027)
8.2 Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Type
8.2.1 Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2027)
8.3 Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Application
8.3.1 Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2027)
8.4 Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Region
8.4.1 Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cyclin Dependent Kinase Inhibitor Market Size (2016-2027)
9.2 Latin America Cyclin Dependent Kinase Inhibitor Market Size by Type
9.2.1 Latin America Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2021)
9.2.2 Latin America Cyclin Dependent Kinase Inhibitor Market Size by Type (2022-2027)
9.2.3 Latin America Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2027)
9.3 Latin America Cyclin Dependent Kinase Inhibitor Market Size by Application
9.3.1 Latin America Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2021)
9.3.2 Latin America Cyclin Dependent Kinase Inhibitor Market Size by Application (2022-2027)
9.3.3 Latin America Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2027)
9.4 Latin America Cyclin Dependent Kinase Inhibitor Market Size by Country
9.4.1 Latin America Cyclin Dependent Kinase Inhibitor Market Size by Country (2016-2021)
9.4.2 Latin America Cyclin Dependent Kinase Inhibitor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size (2016-2027)
10.2 Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Type
10.2.1 Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2027)
10.3 Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Application
10.3.1 Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2027)
10.4 Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Country
10.4.1 Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Cyclin Dependent Kinase Inhibitor Introduction
11.1.4 Eli Lilly Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Cyclin Dependent Kinase Inhibitor Introduction
11.2.4 Pfizer Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Cyclin Dependent Kinase Inhibitor Introduction
11.3.4 Novartis Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Astex Pharmaceuticals
11.4.1 Astex Pharmaceuticals Company Details
11.4.2 Astex Pharmaceuticals Business Overview
11.4.3 Astex Pharmaceuticals Cyclin Dependent Kinase Inhibitor Introduction
11.4.4 Astex Pharmaceuticals Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
11.4.5 Astex Pharmaceuticals Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Cyclin Dependent Kinase Inhibitor Introduction
11.5.4 Merck Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Bio-Techne
11.6.1 Bio-Techne Company Details
11.6.2 Bio-Techne Business Overview
11.6.3 Bio-Techne Cyclin Dependent Kinase Inhibitor Introduction
11.6.4 Bio-Techne Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
11.6.5 Bio-Techne Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Cyclin Dependent Kinase Inhibitor Introduction
11.7.4 Sanofi Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Cyclin Dependent Kinase Inhibitor Introduction
11.8.4 Bayer Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
11.8.5 Bayer Recent Development
11.9 Syros Pharmaceuticals
11.9.1 Syros Pharmaceuticals Company Details
11.9.2 Syros Pharmaceuticals Business Overview
11.9.3 Syros Pharmaceuticals Cyclin Dependent Kinase Inhibitor Introduction
11.9.4 Syros Pharmaceuticals Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
11.9.5 Syros Pharmaceuticals Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Cyclin Dependent Kinase Inhibitor Introduction
11.10.4 Amgen Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
11.10.5 Amgen Recent Development
11.11 BioCAD
11.11.1 BioCAD Company Details
11.11.2 BioCAD Business Overview
11.11.3 BioCAD Cyclin Dependent Kinase Inhibitor Introduction
11.11.4 BioCAD Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
11.11.5 BioCAD Recent Development
11.12 Otsuka Pharmaceutical
11.12.1 Otsuka Pharmaceutical Company Details
11.12.2 Otsuka Pharmaceutical Business Overview
11.12.3 Otsuka Pharmaceutical Cyclin Dependent Kinase Inhibitor Introduction
11.12.4 Otsuka Pharmaceutical Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
11.12.5 Otsuka Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cyclin Dependent Kinase Inhibitor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Broad CDK inhibitors
Table 3. Key Players of Specific CDK inhibitors
Table 4. Global Cyclin Dependent Kinase Inhibitor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cyclin Dependent Kinase Inhibitor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cyclin Dependent Kinase Inhibitor Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cyclin Dependent Kinase Inhibitor Market Share by Regions (2016-2021)
Table 8. Global Cyclin Dependent Kinase Inhibitor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cyclin Dependent Kinase Inhibitor Market Share by Regions (2022-2027)
Table 10. Cyclin Dependent Kinase Inhibitor Market Trends
Table 11. Cyclin Dependent Kinase Inhibitor Market Drivers
Table 12. Cyclin Dependent Kinase Inhibitor Market Challenges
Table 13. Cyclin Dependent Kinase Inhibitor Market Restraints
Table 14. Global Cyclin Dependent Kinase Inhibitor Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cyclin Dependent Kinase Inhibitor Market Share by Players (2016-2021)
Table 16. Global Top Cyclin Dependent Kinase Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclin Dependent Kinase Inhibitor as of 2020)
Table 17. Ranking of Global Top Cyclin Dependent Kinase Inhibitor Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cyclin Dependent Kinase Inhibitor Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cyclin Dependent Kinase Inhibitor Product Solution and Service
Table 21. Date of Enter into Cyclin Dependent Kinase Inhibitor Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cyclin Dependent Kinase Inhibitor Revenue Market Share by Type (2016-2021)
Table 25. Global Cyclin Dependent Kinase Inhibitor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cyclin Dependent Kinase Inhibitor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cyclin Dependent Kinase Inhibitor Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cyclin Dependent Kinase Inhibitor Revenue Market Share by Application (2016-2021)
Table 29. Global Cyclin Dependent Kinase Inhibitor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cyclin Dependent Kinase Inhibitor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cyclin Dependent Kinase Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cyclin Dependent Kinase Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cyclin Dependent Kinase Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cyclin Dependent Kinase Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cyclin Dependent Kinase Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cyclin Dependent Kinase Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cyclin Dependent Kinase Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cyclin Dependent Kinase Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cyclin Dependent Kinase Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cyclin Dependent Kinase Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cyclin Dependent Kinase Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cyclin Dependent Kinase Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 61. Eli Lilly Company Details
Table 62. Eli Lilly Business Overview
Table 63. Eli Lilly Cyclin Dependent Kinase Inhibitor Product
Table 64. Eli Lilly Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021) & (US$ Million)
Table 65. Eli Lilly Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Cyclin Dependent Kinase Inhibitor Product
Table 69. Pfizer Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Cyclin Dependent Kinase Inhibitor Product
Table 74. Novartis Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Astex Pharmaceuticals Company Details
Table 77. Astex Pharmaceuticals Business Overview
Table 78. Astex Pharmaceuticals Cyclin Dependent Kinase Inhibitor Product
Table 79. Astex Pharmaceuticals Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021) & (US$ Million)
Table 80. Astex Pharmaceuticals Recent Development
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Cyclin Dependent Kinase Inhibitor Product
Table 84. Merck Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021) & (US$ Million)
Table 85. Merck Recent Development
Table 86. Bio-Techne Company Details
Table 87. Bio-Techne Business Overview
Table 88. Bio-Techne Cyclin Dependent Kinase Inhibitor Product
Table 89. Bio-Techne Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021) & (US$ Million)
Table 90. Bio-Techne Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Cyclin Dependent Kinase Inhibitor Product
Table 94. Sanofi Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Bayer Company Details
Table 97. Bayer Business Overview
Table 98. Bayer Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021) & (US$ Million)
Table 99. Bayer Recent Development
Table 100. Syros Pharmaceuticals Company Details
Table 101. Syros Pharmaceuticals Business Overview
Table 102. Syros Pharmaceuticals Cyclin Dependent Kinase Inhibitor Product
Table 103. Syros Pharmaceuticals Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021) & (US$ Million)
Table 104. Syros Pharmaceuticals Recent Development
Table 105. Amgen Company Details
Table 106. Amgen Business Overview
Table 107. Amgen Cyclin Dependent Kinase Inhibitor Product
Table 108. Amgen Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021) & (US$ Million)
Table 109. Amgen Recent Development
Table 110. BioCAD Company Details
Table 111. BioCAD Business Overview
Table 112. BioCAD Cyclin Dependent Kinase Inhibitor Product
Table 113. BioCAD Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021) & (US$ Million)
Table 114. BioCAD Recent Development
Table 115. Otsuka Pharmaceutical Company Details
Table 116. Otsuka Pharmaceutical Business Overview
Table 117. Otsuka Pharmaceutical Cyclin Dependent Kinase Inhibitor Product
Table 118. Otsuka Pharmaceutical Revenue in Cyclin Dependent Kinase Inhibitor Business (2016-2021) & (US$ Million)
Table 119. Otsuka Pharmaceutical Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cyclin Dependent Kinase Inhibitor Market Share by Type: 2020 VS 2027
Figure 2. Broad CDK inhibitors Features
Figure 3. Specific CDK inhibitors Features
Figure 4. Global Cyclin Dependent Kinase Inhibitor Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Cyclin Dependent Kinase Inhibitor Report Years Considered
Figure 9. Global Cyclin Dependent Kinase Inhibitor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Cyclin Dependent Kinase Inhibitor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cyclin Dependent Kinase Inhibitor Market Share by Regions: 2020 VS 2027
Figure 12. Global Cyclin Dependent Kinase Inhibitor Market Share by Regions (2022-2027)
Figure 13. Global Cyclin Dependent Kinase Inhibitor Market Share by Players in 2020
Figure 14. Global Top Cyclin Dependent Kinase Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclin Dependent Kinase Inhibitor as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Cyclin Dependent Kinase Inhibitor Revenue in 2020
Figure 16. Global Cyclin Dependent Kinase Inhibitor Revenue Market Share by Type (2016-2021)
Figure 17. Global Cyclin Dependent Kinase Inhibitor Revenue Market Share by Type (2022-2027)
Figure 18. North America Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Cyclin Dependent Kinase Inhibitor Market Share by Type (2016-2027)
Figure 20. North America Cyclin Dependent Kinase Inhibitor Market Share by Application (2016-2027)
Figure 21. North America Cyclin Dependent Kinase Inhibitor Market Share by Country (2016-2027)
Figure 22. United States Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cyclin Dependent Kinase Inhibitor Market Share by Type (2016-2027)
Figure 26. Europe Cyclin Dependent Kinase Inhibitor Market Share by Application (2016-2027)
Figure 27. Europe Cyclin Dependent Kinase Inhibitor Market Share by Country (2016-2027)
Figure 28. Germany Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Cyclin Dependent Kinase Inhibitor Market Share by Region (2016-2027)
Figure 38. China Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cyclin Dependent Kinase Inhibitor Market Share by Type (2016-2027)
Figure 46. Latin America Cyclin Dependent Kinase Inhibitor Market Share by Application (2016-2027)
Figure 47. Latin America Cyclin Dependent Kinase Inhibitor Market Share by Country (2016-2027)
Figure 48. Mexico Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Cyclin Dependent Kinase Inhibitor Market Share by Country (2016-2027)
Figure 54. Turkey Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Cyclin Dependent Kinase Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Eli Lilly Revenue Growth Rate in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
Figure 60. Astex Pharmaceuticals Revenue Growth Rate in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
Figure 62. Bio-Techne Revenue Growth Rate in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
Figure 64. Bayer Revenue Growth Rate in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
Figure 65. Syros Pharmaceuticals Revenue Growth Rate in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
Figure 66. Amgen Revenue Growth Rate in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
Figure 67. BioCAD Revenue Growth Rate in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
Figure 68. Otsuka Pharmaceutical Revenue Growth Rate in Cyclin Dependent Kinase Inhibitor Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界のブルトン型チロシンキナーゼ（BTK）阻害剤市場規模・現状・予測（2021年-2027年） Bruton's tyrosine kinase (Btk), a member of the non-receptor tyrosine kinase Tec family, is a key signaling enzyme expressed in all hematopoietic cell types except T lymphocytes and natural killer cells.Btk plays a crucial role in stimulating B cell signaling pathways that connect the cell surface B…- 世界のVEGF/VEGFR阻害薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global VEGF/VEGFR Inhibitor Drugs Market The global VEGF/VEGFR Inhibitor Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …
- 世界の血漿プロテアーゼC1阻害剤治療市場規模・現状・予測（2021年-2027年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…
- 世界のモノアミン酸化酵素阻害薬（MAOI）市場規模・現状・予測（2021年-2027年） MAOIs are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B). They are widely used as anti-depressants. Market Analysis and Insights: Global Monoamine Oxidase Inhibitor (MAOIs) Market The global Monoamine O…
- 世界のPARP阻害剤バイオマーカーサービス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global PARP Inhibitor Biomarkers Service Market The global PARP Inhibitor Biomarkers Service market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high da…